174 related articles for article (PubMed ID: 37033269)
1. Log odds of negative lymph nodes/T stage ratio (LONT): A new prognostic tool for differentiated thyroid cancer without metastases in patients aged 55 and older.
Wang X; Wu Y; Li X; Hong J; Zhang M
Front Endocrinol (Lausanne); 2023; 14():1132687. PubMed ID: 37033269
[TBL] [Abstract][Full Text] [Related]
2. The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients.
Xie J; Pang Y; Li X; Wu X
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2259-2269. PubMed ID: 34003367
[TBL] [Abstract][Full Text] [Related]
3. Predictive Value of the Log Odds of Negative Lymph Nodes/T Stage as a Novel Prognostic Factor in Bladder Cancer Patients After Radical Cystectomy.
Chen T; Zhan X; Chen X; Jiang M; Wan H; Fu B; Chen L
Front Oncol; 2022; 12():895413. PubMed ID: 35928878
[TBL] [Abstract][Full Text] [Related]
4. DOES T STAGE AFFECT PROGNOSIS IN PATIENTS WITH STAGE IV B DIFFERENTIATED THYROID CANCER?
Li M; Trivedi N; Dai C; Mao R; Wang Y; Ning Y; Gu SZ; Huo L; Siddiqui AD
Endocr Pract; 2019 Sep; 25(9):877-886. PubMed ID: 31170365
[No Abstract] [Full Text] [Related]
5. Prognostic and Predictive Model of the Log Odds of the Negative Lymph Node/T Stage Ratio in Resectable Gastric Adenocarcinoma Patients.
Yang W; Lu S; Ge F; Hua Y; Chen X
J Gastrointest Surg; 2022 Aug; 26(8):1743-1756. PubMed ID: 35831692
[TBL] [Abstract][Full Text] [Related]
6. The Positive Lymph Node Number and Postoperative N-Staging Used to Estimate Survival in Patients with Differentiated Thyroid Cancer: Results from the Surveillance, Epidemiology, and End Results Dataset (1988-2008).
Wei WJ; Lu ZW; Wen D; Liao T; Li DS; Wang Y; Zhu YX; Wang ZY; Wu Y; Wang YL; Ji QH
World J Surg; 2018 Jun; 42(6):1762-1771. PubMed ID: 29185020
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the prognostic value and N1b changes of the eighth TNM/AJCC staging system for differentiated thyroid carcinoma.
Zhi J; Wu Y; Hu L; Zhao J; Liu H; Ruan X; Hou X; Zhang J; Zheng X; Gao M
Int J Clin Oncol; 2020 Jan; 25(1):59-66. PubMed ID: 31414270
[TBL] [Abstract][Full Text] [Related]
8. Central Lymph Node Status has Significant Prognostic Value in the Clinically Node-Negative Tall-Cell Variant of Papillary Thyroid Cancer Regardless of T-Staging and Radioactive Iodine Administration: First Evidence From a Population-Based Study.
Shi X; Huang NS; Lei BW; Song KH; Shi RL; Wei WJ; Hu WP; Dong F; Wang Y; Wang YL; Ji QH
Ann Surg Oncol; 2018 Aug; 25(8):2316-2322. PubMed ID: 29845406
[TBL] [Abstract][Full Text] [Related]
9. Differentiated thyroid cancer presenting with distant metastases: a population analysis over two decades.
Goffredo P; Sosa JA; Roman SA
World J Surg; 2013 Jul; 37(7):1599-605. PubMed ID: 23525600
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of prior malignancy history in stage I differentiated thyroid cancer: a SEER-based study.
Wang Y; Li S; Xu F; Hao Q
Transl Cancer Res; 2023 May; 12(5):1241-1253. PubMed ID: 37304545
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
12. The assessment of the optimal number of examined lymph nodes and prognostic models based on lymph nodes for predicting survival outcome in patients with stage N3b gastric cancer.
Guo S; Shang M; Dong Z; Zhang J; Wang Y; Zhao Y
Asia Pac J Clin Oncol; 2021 Apr; 17(2):e117-e124. PubMed ID: 32762113
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing synchronous from metachronous manifestation of distant metastases: a prognostic feature in differentiated thyroid carcinoma.
Sabet A; Binse I; Dogan S; Koch A; Rosenbaum-Krumme SJ; Biersack HJ; Biermann K; Ezziddin S
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):190-195. PubMed ID: 27530124
[TBL] [Abstract][Full Text] [Related]
14. Recurrence factors and prevention of complications of pediatric differentiated thyroid cancer.
Wang C; Chen X; Wei X; Chen F; Wang Y; Shen Z
Asian J Surg; 2017 Jan; 40(1):55-60. PubMed ID: 27697309
[TBL] [Abstract][Full Text] [Related]
15. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
[TBL] [Abstract][Full Text] [Related]
17. Have 2006 ATA practice guidelines affected the treatment of differentiated thyroid cancer in the United States?
Goffredo P; Roman SA; Sosa JA
Thyroid; 2014 Mar; 24(3):463-71. PubMed ID: 23978295
[TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics-Assisted Risk Stratification for Extent of Thyroidectomy in Patients With 1-4 cm Solitary Intrathyroidal Differentiated Thyroid Cancer.
Dong F; Zhou L; Wang S; Mao J; Liu C; Shi W
Front Endocrinol (Lausanne); 2021; 12():790730. PubMed ID: 35211090
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes and prognostic factors in patients with no less than three distant organ system metastases from differentiated thyroid carcinoma.
Zhang XY; Sun JW; Qiu ZL; Wang Y; Chen XY; Zhao JH; Luo QY
Endocrine; 2019 Nov; 66(2):254-265. PubMed ID: 31317522
[TBL] [Abstract][Full Text] [Related]
20. DEATH RELATED TO PULMONARY METASTASIS IN PATIENTS WITH DIFFERENTIATED THYROID CANCER.
Leite AK; Kulcsar MA; de Godoi Cavalheiro B; de Mello ES; Alves VA; Cernea CR; Matos LL
Endocr Pract; 2017 Jan; 23(1):72-78. PubMed ID: 27749128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]